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ABSTRACT
The theoretical debate about the underlying 
mechanisms responsible for the production of ultrasonic 
vocalizations is ongoing. The traditional view is that 
ultrasonic vocalizations are a component of communication 
leading to attachment or a survival response, while the 
other perspective is that ultrasonic vocalizations are a 
physiological by-product caused mainly by co'ld stress.
The kappa opioid receptor system is known to mediate 
ultrasonic vocalization production, because the kappa , 
opioid agonist U50,448 elicits ultrasonic vocalizations. 
The purpose of this thesis was to determine whether the 
kappa opioid receptors modulating ultrasonic vocalizations 
production are located in the central and/or peripheral 
nervous system. It was hypothesized that peripheral 
administration of U50,488 or ICI 204,448 (an agonist that 
does not cross the blood-brain barrier) would increase 
ultrasonic vocalizations and reduce rectal temperatures of 
11-day-old rats. As hypothesized, both ICI 204,448 and 
U50,488 increased ultrasonic vocalization production, but 
neither drug affected rectal temperatures. This pattern of 
results indicates that peripherally-located kappa opioid 
receptors are involved in the mediation of ultrasonic 
vocalization production. Interestingly, both ICI 204,448 
iii
and U50,488 also increased the locomotor activity of 
preweanling rats. While this result may suggest that ICI 
204,448 crosses the blood-brain barrier, a more 
parsimonious conclusion is that stimulation of 
peripherally-located kappa opioid receptors is able to 
initiate locomotor activity. In conclusion, kappa opioid 
receptors are located on neuroanatomical structures that 
could induce ultrasonic vocalizations by either altering 
the emotional state of the animal or by causing abdominal 
compression reactions. However, neither U50,448 nor ICI 
204,448 decreased rectal temperatures (as the abdominal 
compression reaction hypothesis would predict), so the 
present results are more consistent with the traditional 
view of ultrasonic vocalization production. Specifically, 
these findings suggest that peripherally-located kappa 
opioid receptors are, at least partially, responsible for 
ultrasonic vocalizations by acting on autonomic structures 
that alter emotional states (e.g., stress). The kappa 
opioid receptor system is preserved throughout all 
mammalian species, including humans, thus it is possible 
that the same neural substrates underlie infant 
vocalizations across species.
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CHAPTER ONE
HUMAN ATTACHMENT AND RESPONSE TO INFANT 
AND CHILD COMMUNICATIONS
Attachment is a primary cornerstone of human 
development. The attachment system appears to provide a 
primal safety measure hardwired into the brain from birth 
to satisfy the biological needs involved in survival 
through proximity to the caregiver (Newman, 2007) . 
Physiological expressions such as crying are often due to 
distress from discomfort, such as cold or heat exposure, 
hunger, fear or need for contact with others (comfort or 
socialization) (Bowlby, 1973, 1988; Lummaa & Vuorialo, 
1998; Seifritz, Esposito, Neuhoff, Luthi, Mustovic, 
Dammann, Bardeleben, Radue, Cirillo, Tedeschi, & Di Salle, 
2003). As conceived by Bowlby (1988), attachment theory in 
infants is the process of proximity-seeking to maintain or 
provoke a closeness to a known attachment figure (i.e., 
caregiver), which could be considered a survival 
mechanism. Through this mechanism, the infant becomes 
attached to any caregiver that responds to the infant's 
perceived distress or alarm (cries) with sensitive and 
responsive social interactions (Bowlby, 1973; Lummaa & 
Vuorialo, 1998; Seifritz et al., 2003; Stormark, 2007).
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Infant crying has long been considered to be a form of 
communication between parent and infant (Newman, 2007). In 
the early stages of development, crying is a primitive 
biological survival response that elicits maternal 
retrieval to satisfy a discomfort, such as hunger, cold, 
separation, or other situations that could result in harm 
or death (Lummaa & Vuorialo, 1998; Newman, 2007; Seifritz 
et al., 2003). These primitive biological cries develop 
into maternal bonds and are the building blocks of 
communication. These cries have unique tonal qualities 
that, elicit different responses from the maternal 
caregiver (Lummaa & Vuorialo, 1998; Seifritz et al., 
2003). Eventually, more sophisticated communications 
develop (speech and language) and become the tools that 
humans utilize to share thoughts and ideas (Jurgen & 
Ploog, 2003). Language is expressed through speech, 
signaling (gestures), or writing; however, communications 
can be as primitive as sounds or movements, which are 
sometimes seen in the animal world. These sounds or 
movements can be utilized to provoke specific responses 
such as retrieval or an alert for safety or distress 
(Jurgen & Ploog, 2003; Newman, 2007).
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Brain Circuitry and Human Maternal Behavior
There is little known about what brain circuitry 
mediates the maternal response to distress calls (cries) 
of human infants (Lorberbaum, Newman, Horwitz, Dubon, 
Lydiard, Hamner, Bohning, & George, 2002; Noriuchi, 
Kikuchi, & Senoo, 2008). It is understood that these cries 
provoke a maternal response that is related to the 
survival of the species and helps in the development of 
attachment (Ainsworth, 1978; Bowlby, 1973; Noirot, 1972; 
Seifritz et al., 2003; Stormark, 2007). Lorberbaum et al. 
(2002) utilized magnetic resonance imaging to measure the 
effects of cries on the brain activity of young first-time 
human mothers. It was found that cries evoked more 
emotional symptoms (sadness) than did control noises 
(Lorberbaum et al., 2002; Seifritz et al., 2003). When 
control noises were conducted without the cries, they 
produced more negative'emotions (annoyance) than cries 
(Lorberbaum et al., 2002; Seifritz et al., 2003). Magnetic 
Resonance Imaging (MRI) showed that crying alone (without 
the control noise) activated the anterior and posterior 
cingulate cortex, medial thalamic nuclei, bilateral mesial 
prefrontal cortex, and right orbitofrontal cortex 
(Lorberbaum et al., 2002; Noriuchi et al., 2008; Seifritz, 
et al., 2003).
3
Human and Animal Homologues
Numerous studies utilize animal models for 
understanding brain behavior results in humans; however, 
it can be difficult to prove commonalities between species 
(Newman, 2007). That being said, vocalizations in animals 
are a form of communication and it is common for the 
ultrasonic vocalizations of young animals to be compared 
to the cries of human infants (Newman, 2007). Although 
ultrasonic vocalizations of rats are measured in terms of 
the number and intensity of vocalizations and by maternal 
retrieval, human infant cries are often measured in terms 
of maternal responses to questions and by magnetic 
resonance imaging to determine which areas of the brain 
are active (Nelson & Panksepp, 1998; Seifritz et al., 
2003). Even though the techniques used to study 
vocalizations differ according to species, the neural 
mechanisms underlying the vocalizations of humans and 
other mammals share biological similarities (Newman, 
2007). For example, the amygdala is a common mechanism 
activated during crying in primates, rodents, and humans 
(Lorberbaum et al., 2002; Newman, 2007; Noriuchi et al., 
2008; Seifritz, 2003), as well as the anterior cingulate 
gyrus, which becomes active in both primates and humans 
(Newman, 2007). Thus, there is substantial evidence that
4
crying in various mammalian species shares common neural
mechanisms.
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CHAPTER TWO
THEORETICAL PERSPECTIVES OF ULTRASONIC 
VOCALIZATIONS
Although ultrasonic vocalizations of young rodents 
have been actively studied since 1956 (Rabon, Sawrey, & 
Webster, 2001), there is a growing theoretical debate 
about the underlying mechanisms responsible for the 
production of ultrasonic vocalizations (Blumberg, 
Sokoloff, & Kent, 1999). The traditional view is that 
ultrasonic vocalizations are a component of communication 
or a survival response, such as eliciting maternal 
retrieval (Lorberbaum et al., 2002; Newman, 2007; Noriuchi 
et al., 2008). More recently it has been suggested that 
ultrasonic vocalizations are a physiological effect (i.e., 
an "acoustic by-product") caused by a cardiovascular 
process called the abdominal compression reaction 
(Blumberg et al., 1999; Blumberg, Sokoloff, & Kent, 
2000a).
Traditional View of Ultrasonic Vocalizations
Traditionally, ultrasonic vocalizations have been 
identified as a system of communication between infant and 
adult rodents (Hahn & Lavooy, 2005; Hofer & Shair, 1978; 
Lorberbaum et al., 2002; Newman, 2007; Noriuchi et al., 
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2008). For instance, in rodents, such as rats, the anxiety 
from being under cold stress or separated from the dam or 
littermates evokes the pup to vocalize and increase their 
locomotor activity (Allin & Banks, 1971, 1972; Brunelli, 
Shair, & Hofer, 1994; Hofer & Shair, 1978). Thus, 
ultrasonic vocalizations were interpreted as a distress 
response produced by young animals to elicit parental 
retrieval due to these stressful factors (Allin & Banks, 
1971, 1972; Hofer & Shair, 1978; Lorberbaum et al., 2002; 
Newman, 2007; Noirot, 1972; Noriuchi et al., 2008).
Furthermore, these ultrasonic vocalizations appear to have 
an important survival value for the pups by eliciting 
maternal care such as directed search (retrieval behavior) 
and licking. It has also been shown that the playback of 
ultrasonic vocalizations can induce stimulus-directed 
search behavior by the dam (Allin & Banks, 1972; Noriuchi 
et al., 2008; Wohr, Borta, & Schwarting, 20'05). Distress 
calls of rodents also act as a main elicitor of anogenital 
licking (Bruuette-Lahlou, Vernet-Maury, & Vigouroux, 
1992). This licking is vital to the survival of the young 
pups by inducing defecation.
Considering the negative effect of separation (i.e., 
survival, separation anxiety, being under cold stress, and 
lack of other maternal nurturing), it appears that 
7
ultrasonic, vocalizations are a valid index of anxiety 
(Hahn & Lavooy, 2005). In support of the hypothesis that 
separation-induced ultrasonic vocalizations are a 
predictor of anxiety, it has been shown that the rate of 
calling can be attenuated by anxiolytic (anxiety reducing) 
drugs (Hofer, 1996; Insel, Hill, & Mayor, 1986; Kehne, 
McCloskey, Baron, Chi, Harrison, Whitten, & Palfreyman, 
1991; Olivier, Molewijk, Der Heyden, Van Oorschot, Ronken, 
Mos, & Miczek, 1998; Vivian, Barros, Manitiu, & Miczek, 
1997). More recently, Rabon et al. (2001) showed that when 
ultrasonic vocalizations were at their highest rate of 
production, the retrieval response was the shortest, thus 
providing additional evidence that the function of infant 
ultrasonic vocalizations is to facilitate parental 
responsiveness to retrieve the pups.
Although ultrasonic vocalizations are hypothesized to 
elicit a maternal response and guide the mother to the • 
lost pup, it is uncertain what characteristics of 
ultrasonic vocalizations elicit maternal behaviors. 
According to Brudzynski, Kehoe, and Callahan (1999), it is 
difficult to differentiate the critical components due to 
the extreme variability in acoustic parameters. It appears 
that rat pups do not utilize a single acoustic parameter 
to code the quantitative message dimensions, but all 
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parameters (single-call duration, sound-peak frequency, 
and bandwidth) aid the mother in determining the pup's 
location. By using a recording system (sonograph) that is 
capable of monitoring a wide range of frequency 
modulations, Brudzynski et al. (1999) were able to 
determine those call characteristics produced by the pups 
that are important for survival by producing a maternal 
retrieval response. It was shown that those call 
characteristics the pups produce, like amplitude, 
frequency modulation, and short period structure, are all 
related to the amount of maternal care that the pups 
experienced during early life (see also Wohr et al., 
2005).
It has been speculated that the greater the number of 
ultrasonic vocalizations the shorter the latency until 
maternal responding. To determine if the greater number of 
pup vocalizations would alone determine the length of time 
taken before maternal response, research conducted by 
Keller, Saucier, Sheerin, and Yager (2004) utilized 
heat-induced convulsions to determine if increased body 
temperature would increase ultrasonic vocalization 
production and enhance mother-pup interactions. Pups 
subjected to the higher temperatures did elicit more 
ultrasonic vocalizations than controls that were not 
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subjected to the higher temperatures. However, it was 
shown by Keller et al. (2004) that mother-pup interactions 
did not significantly differ between heat-induced and 
control groups despite greater numbers of ultrasonic 
vocalizations induced by these higher temperatures. 
Interestingly, it appears that female pups, despite 
calling more frequently than their male littermates, 
received the lowest amount of maternal care (Keller et 
al., 2004), possibly due to the less efficient ultrasonic 
vocalization production or insufficient call 
characteristics (see Brudzynski et al., 1999). This 
heat-induced convulsion study shows that heat stress 
provokes a reflexive form of vocalization, but it appears 
that the structural acoustic intensity of the ultrasonic 
vocalizations or the characteristics of the ultrasonic 
vocalizations determine what behavior will be elicited 
from the dam and that the number of ultrasonic 
vocalizations are not the controlling factor (Keller et 
al., 2004).
When considering the negative effects of separation, 
the lack of maternal response elicited by heat-induced 
ultrasonic vocalizations, and the various acoustic 
parameters utilized (single-call duration, sound-peak 
frequency, and bandwidth), these various results support 
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the traditional view that ultrasonic vocalizations are a 
true form of intraspecies communication and that these 
structured signals convey a recognizable sign that 
provokes predictable behaviors in the recipient.
Ultrasonic Vocalizations As A
Physiological Side Effect
Blumberg and colleagues have challenged the 
traditional view that ultrasonic vocalizations are a 
distress response produced by young animals to elicit 
parental retrieval (see Allin & Banks, 1971, 1972; Hofer & 
Shair, 1978; Noirot, 1972). Instead, they have argued that 
ultrasonic vocalizations are an. "acoustic by-product" of a 
.cardiovascular process called the abdominal compression 
reaction (Blumberg et al., 1999; Blumberg, Sokoloff, & 
Kent, 2000b). According to this interpretation, cold 
stress causes a reduction in heart rate and venous blood 
flow thus reducing body temperature. To combat this 
situation, the young animal involuntarily engages in 
abdominal compression reactions that result in increased 
blood pressure and therefore a concomitant increase in 
ultrasonic vocalizations (an involuntary reaction due to 
the body trying to minimize the cold stress) (Blumberg et 
al., 1999, 2000b).
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Further studies conducted by Blumberg et al. (1999) 
found that brain activity was altered at various 
temperatures. After prolonged periods of exposure to 
temperatures of 18-22 °C, with core temperatures falling to 
levels below 27 °C, pups vocalize while exhibiting high 
levels of locomotor activity (Blumberg et al., 1999; 
Sokoloff, Kirby, & Blumberg, 1998). Karlsson and Blumberg 
(2003) found increased spontaneous hippocampal activity 
along the dentate gyrus axis at body temperatures of 37° 
and 27 °C, indicating that cold temperature also induced 
reciprocal activation of the hippocampal network, causing 
oscillations between sustained rhythms and sharp brain 
waves.
The increase in ultrasonic vocalizations not only 
takes place when the animal is under extreme cold exposure 
but also after administration of drugs like clonidine 
(Kehoe & Harris, 1989) . Clonidine is a c<2-adrenoceptor 
agonist that mimics the action of norepinephrine by 
directly binding to the receptor. According to Blumberg 
and colleagues, increases in ultrasonic vocalizations are 
elicited by, and associated with, enhanced venous pressure 
(Kirby & Blumberg, 1998). Enhanced venous pressure, in 
turn, results from the body trying to regain equilibrium 
by involuntarily compensating through a process known as 
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abdominal compression reactions, which is due to decreased 
cardiac rate and stroke volume (Blumberg et al., 1999, 
2000b). According to Blumberg et al. (2000a) both cold 
exposure and clonidine are capable of decreasing cardiac 
rate and stroke volume and, through these mechanisms, 
cause an increase in ultrasonic vocalization production. 
Teitel, Sidi, Chin, Brett, Heymann, and Rudolph (1985) 
found that infant mammals are limited in their ability to 
increase stroke rate above basal levels, thus inhibiting 
their ability to compensate for temperature-or 
clonidine-induced reductions in cardiac output.
Allin and Banks (1971) suggested that thermal cues 
are the primary factor .determining whether ultrasonic 
vocalizations are emitted and that other factors (e.g., 
isolation from the nest, vestibular, olfactory, and 
tactile information) are not as critical for eliciting the 
production of ultrasonic vocalizations. Blumberg, Efimova, 
and Alberts (1992a, b) found that isolation from the nest, 
dam, and littermates must be accompanied by significant 
cold stress for the resulting ultrasonic vocalizations to 
be of significant volume and frequency to instigate a 
maternal response. More recent studies have refined the 
process of studying how young rodents react to 
temperature-induced stressors. For instance, Blumberg and 
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Stolba (1996) removed pups from the nest and allowed them 
to acclimate to a warm environment before being exposed to 
cold. Using this procedure, ultrasonic production 
increased dramatically across the transition from moderate 
to extreme cold exposure when the pup could no longer 
compensate for the loss of body heat. These and similar 
studies have concluded that ultrasonic vocalizations are a 
by-product of a physiological, maneuver referred to as 
abdominal compression reaction (Youmans, Murphy, Davis, 
Briggs, & Hoye, 1963), which enhances venous return during 
extreme thermal challenges (Kirby & Blumberg, 1998).
The latter results are consistent with the position 
of Blumberg and colleagues, however, other evidence is 
more consistent with the traditional view about ultrasonic 
vocalizations. For example, the abdominal compression 
reaction hypothesis does not take into consideration 
magnitude differences in the frequency, single-call 
duration, sound-peak frequency, and bandwidth of 
ultrasonic vocalizations. Moreover, the thermogenic 
response to isolation at room temperature is not 
influenced by devocalization and brown adipose tissue 
stimulation is not necessary for the ultrasonic 
vocalization response to cold (Hofer & Shair, 1991). 
Therefore, when all the evidence is considered together, 
14
it is uncertain which theory about ultrasonic vocalization 
production is correct.
15
CHAPTER THREE
NEUROTRANSMITTER SYSTEMS
Neurotransmitters are chemicals that are used to 
modulate, amplify, and relay signals between a neuron and 
other cells. Agonists are exogenous substances that bind 
to.specific receptors and trigger responses in the cell. 
For example, in the present thesis two kappa opioid 
agonists (ICI 204,488 and U50,488) were used. Both 
agonists attach to kappa opioid receptors and stimulate 
them.
The neural mechanisms mediating ultrasonic 
vocalizations have been studied intensively, and various 
neurotransmitter systems have been implicated (Kehoe & 
Harris, 1989) . Three of the most prominent 
neurotransmitter systems involved in ultrasonic 
vocalizations are the y-aminobutyric acid (GABA), 
adrenergic, and kappa opioid systems. GABA receptors are 
widely dispersed across brain and, when stimulated, 
ultrasonic vocalizations^ are reduced (Adachi, Tomonaga, 
Achibana, Denbow, & Furuse, 2006). Stimulation of 
o^-adrenoceptors affects ultrasonic vocalization 
production through centrally acting receptors in the brain 
that monitor catecholamine levels in blood (Kehoe &
16
Harris, 1989). The kappa opioid system plays a role in 
ultrasonic vocalization production because kappa opioid 
receptor agonists significantly increase ultrasonic 
vocalization emissions (Blumberg, Sokoloff, Kirby, Knoot, 
& Lewis, 2002; Carden, Barr, & Hofer, 1991; Kehoe & 
Harris, 1989; Nazarian, Krall, Osburn, & McDougall, 2001) .
y-Aminobutyric Acid
GABA is the major inhibitory neurotransmitter in the 
central nervous system; it is essential for the overall 
balance between neuronal excitation and inhibition (Adachi 
et al., 2006). Drugs that stimulate GABA receptors 
decrease ultrasonic vocalizations (Carden & Hofer, 1991) . 
For example, ultrasonic vocalizations can be elicited by 
injecting histamine, glutamate, or acetylcholine agonists; 
however, all of.these chemically-induced vocalizations can' 
be blocked by the GABA agonist muscimol (Adachi et al., 
2006; Whiting, 2003). Consistent with these findings, GABA 
receptor antagonists are c’apable of attenuating the 
suppressive effects of flesinoxan (a GABA agonist) on 
isolation-induced vocalizations (Adachi et al., 2006). 
These findings suggest that GABAergic mechanisms are 
involved in mediating ultrasonic vocalization production.
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a2-Adrenoceptors
Stimulation of c<2-adrenoceptors increases ultrasonic 
vocalization production in preweanling rat pups; however, 
it is uncertain whether these vocalizations are due to 
modulating distress and anxiety (e.g., Kehoe & Harris, 
1989), or by altering cardiovascular functioning (e.g., 
Blumberg & Sokoloff, 2001; Blumberg et al., 2000b). 
Regardless, it does appear that the critical 
a2-adrenoceptors mediating ultrasonic vocalization 
production are located centrally rather than peripherally., 
Specifically, peripheral administration of the lipophilic 
a2~adrenoceptor agonist clonidine, which easily crosses 
the blood-brain barrier, increases ultrasonic 
vocalizations; whereas, peripheral administration of the 
hydrophilic a2-adrenoceptor agonist ST-91, which does not 
readily cross the blood-brain barrier, does not affect 
ultrasonic vocalizations (Krall, Andicochea, & McDougall, 
2005). Both clonidine and ST-91 increase ultrasonic 
vocalizations when directly administered into the third 
ventricle, thus confirming that ultrasonic vocalization 
production is modulated by a2-adrenoceptors located in 
brain (Krall et al., 2005).
Clonidine is a centrally acting a2-adrenoceptor 1
agonist that selectively stimulates receptors in brain
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that monitor catecholamine levels in blood. In humans, 
clonidine is used for the treatment of Attention Deficit 
Hyperactivity Disorder to alleviate opiate withdrawal 
symptomology (tachycardia) and for hypertension (Coull, 
Sahakian, Middleton, Young, Park, McShane, Cowen, & 
Robbins, 1995; Hunt, Minderra, & Cohen, 1985; Ozdogan, 
Lahdesmaki, & Scheinin, 2003; Wang, Yuan, & Su, 2003; 
Zalunardo, Zollinger, Spahn, Seifert, & Pasch, 2000). 
Clonidine also differentially affects the ultrasonic 
vocalizations of rats depending on age (Hard, Engel, & 
Lindh, 1988). Results showed that clonidine elevated 
ultrasonic vocalizations in 2- to 4-day-old pups, whereas 
6-day-old pups showed a pronounced increase in 
clonidine-induced ultrasonic vocalizations that continued 
to increase with age. Clonidine also enhanced the number 
of ultrasonic vocalizations in 12-day-old rats, an age 
when the number of vocalizations normally decreases (Hard 
et al., 1988). Interestingly, the excitatory effects of 
clonidine on ultrasonic vocalization production stopped 
abruptly at 20 days of age (Hard et al., 1988), most 
likely due to the rat transitioning to later developmental 
. stages when ultrasonic vocalizations do not confer an
evolutionary advantage. Consistent with these findings, it 
was also reported that the (^-adrenoceptor agonist 
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clonidine increased ultrasonic vocalizations in 10-day-old 
rat pups. Unlike in the normal isolated rat pup, however, 
the ultrasonic vocalizations of clonidine-treated pups 
appeared resilient to maternal cues, because the pups 
continued to vocalize even following retrieval (Hansen, 
1993) .
In summary, the o^-adrenoceptor agonist clonidine 
substantially increases the ultrasonic vocalization 
production of young rats (Thiessen & Upchurch, 1981). The 
neural mechanisms responsible for this clonidine-induced 
effect are uncertain but a number of possibilities are 
apparent. First, clonidine may stimulate a2-adrenoceptors 
in brain regions responsible for mediating distress and 
anxiety (Kehoe & Harris, 1989). Second, a2-adrenoceptor 
agonists are capable of decreasing heart rate and blood 
pressure through central mechanisms (McAuley, Macrae, & 
Reid, 1989; Wang, Macmillan, Fremeau, Magnuson, Lindner, & 
Limbird, 1996) , which may indirectly enhance ultrasonic 
vocalization production by initiating abdominal 
compression reactions (see Blumberg et al., 1999, 2000a). 
Third, stimulation of a2-adrenoceptors located on 
postganglionic fibers causes hypotension and bradycardia 
(Blumberg et al., 2000a), thus potentially increasing 
ultrasonic vocalizations through peripheral mechanisms.
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The latter possibility appears unlikely, however, because 
ultrasonic vocalization production is not altered after 
peripheral administration of ST-91 (a o^-adrenoceptor 
agonist that does not readily cross the blood-brain 
barrier) (Krall et al., 2005).
Kappa Opioid System
The kappa opioid system is responsible for regulating 
reward, locomotor activity, and pain perception (Gardner, 
2005; Przewlocki, 2004). These receptors are located in 
the periphery on pain neurons, in the spinal cord, and in 
the brain (Zhu & Pan, 2004). It has been shown that 
systemic (peripheral) administration of kappa opioid 
agonists, such as U50,488, increase the ultrasonic 
vocalizations of preweanling rats (Barr, Wang, & Carden, 
1994; Carden et al., 1991; Carden, Bortot, & Hofer, 1993; 
Carden, Davachi, & Hofer, 1994; Kehoe & Boylan, 1994; 
Kehoe & Harris, 1989; Nazarian et al., 2001; Nazarian, 
Rodarte-Freeman, & McDougall, 1999). However, these 
studies have been unable to determine whether the critical 
kappa opioid receptors modulating ultrasonic vocalizations 
are located in the central nervous system or peripheral 
nervous system, because (a) kappa agonists are typically 
administered systemically (peripherally) and (b) U50-, 488
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freely crosses the blood-brain barrier. Clearly, at least 
one of the populations of kappa opioid receptors are 
located centrally, because infusing U50,488 into the 
midbrain periaqueductal gray readily elicits ultrasonic 
vocalizations in one-week-old rats (Goodwin & Barr, 2005).
These findings suggest that kappa opioid receptors 
located in the periaqueductal gray area play an important 
role in mediating the production ■ of ultrasonic 
vocalizations (Goodwin & Barr, 2005). However, two 
questions remain. First, are the kappa opioid receptors 
mediating ultrasonic vocalizations production exclusively 
located in the central nervous system (brain and spinal 
cord) or are there peripherally located kappa opioid 
receptors that also mediate ultrasonic vocalization 
production? Second, do these various kappa opioid 
receptors affect ultrasonic vocalization production by 
modulating distress or cardiovascular functioning 
(activation of receptors in the brain or peripherally 
located receptors on the heart)? In the latter case, kappa 
opioid receptors located on postganglionic fibers in the 
brain and in heart tissue are known to induce both 
bradycardia and hypotension (Pugsley, Penz, Walker, & 
Wong, 1992). Furthermore, there is evidence that 
stimulation of kappa opioid receptors in the hippocampus, 
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hypothalamus, medulla and, to a lesser extent, the 
periaqueductal gray decreases heart rate and blood 
pressure of adult rats (Feuerstein & Faden, 1982; Wang & 
Ingenito, 1994), thus providing evidence that centrally 
located kappa receptors can affect heart rate. Thus, 
systemic or central treatment with selective kappa opioid 
agonists may stimulate ultrasonic vocalization production 
by'depressing cardiovascular functioning (Hannsen, 
Feuerstein, & Faden, 1984). It also remains possible that 
stimulation of centrally-located kappa opioid receptors 
induces ultrasonic vocalization production by directly 
modulating stress or anxiety circuits in the brain.
Interestingly, U50,488 has been implicated in the 
mediation of locomotor activity as well as ultrasonic 
vocalizations. It has been shown that administration of 
U50,488 increases locomotor activity in preweanling rats 
(Carden et al., 1991; Jackson & Kitchen, 1989; Nazarian et 
al., 1999), while depressing locomotor activity in adult 
rats (Di Chiara & Imperato, 1988; Leyton & Stewart, 1992). 
The locus of U50,488's locomotor activating effect has 
been of much interest. For example, Barr, Miya, and 
Paredes (1992) suggest that kappa opioid agonists increase 
locomotor activity through both spinal and supraspinal 
mechanisms. Conversely, microinjecting U50,488 into the 
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substantia nigra pars reticulata increase locomotor 
activity of both preweanling and adult rats (Collins, 
Zavala, Nazarian, & McDougall, 2000).
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CHAPTER FOUR
SUMMARY AND HYPOTHESES
The purpose of this thesis was to determine whether 
stimulating kappa opioid receptors in the peripheral 
nervous system is capable of eliciting ultrasonic 
vocalization production. This thesis was not designed to 
directly determine whether kappa opioid receptor 
stimulation induces ultrasonic vocalizations by modulating 
distress systems or cardiovascular functioning except to 
the extent that peripherally located receptors would not 
typically be part of a neural network (central nervous 
system) responsible for inducing voluntary motor activity, 
mediating distress or emotion.
To determine whether centrally- or 
peripherally-located kappa opioid receptors mediate 
ultrasonic vocalization production, I compared the effects 
of U50,488 (a kappa opioid agonist- that freely crosses the 
blood-brain barrier) with ICI 204,448 (a kappa opioid 
agonist that does not readily cross the blood-brain 
barrier) (Shaw, Carroll, Alcock, & Main, 1989) . More 
precisely, 11-day-old rats were injected with saline (a 
control substance), U50,488, (a lipophilic compound) or 
various doses of ICI 204,448 (a lipophobic compound).
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Ultrasonic vocalization production was assessed for 20 
minutes after which rectal temperatures were measured. It 
was hypothesized that administration of ICI 204,448 would 
increase the production of ultrasonic vocalizations by 
lowering the heart rate and decreasing body temperature. 
This pattern of results would mean that ultrasonic 
vocalizations are partially mediated by 
peripherally-located kappa opioid receptors. This finding 
would be in opposition to the current belief that 
centrally-located kappa opioid receptors exclusively 
mediate ultrasonic vocalization production (see Goodwin & 
Barr, 2005).
Although ICI 204,448 is proposed to be unable to 
cross the blood-brain barrier (Shaw et al., 1989), we 
measured U50,488- and ICI 204,448-induced locomotor 
activity as a control to assess whether ICI 204,448 was 
able to enter the central nervous system. Specifically 
U50,488 dramatically increases the locomotor activity of 
preweanling rats (Jackson & Kitchen, 1989; Kehoe & Boylan, 
1994; Kehoe & Harris, 1989; Nazarian et al., 2001; 
Nazarian et al., 1999; Zavala, Yoshida, Osburn, & 
McDougall, 2002), and microinjection studies indicate that 
this kappa opioid agonist induces locomotor activity by 
stimulating receptors in the substantia nigra pars
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reticulata (Collins et al., 2000) . In terms of ICI
204,448, however, this hydrophobic kappa opioid agonist 
has limited ability to cross the blood-brain barrier and 
gain access to the central nervous system (Barber, 
Bartoszyk, Greiner, Mauler, Seyfrie, Simon, Gottschlich, 
Harting, & Lues 1994; Shaw et al., 1989); therefore, ICI
204,448 should not induce locomotor activity in 
preweanling rats if: (a) ICI 204,488 does not cross the 
blood-brain barrier and (b) the kappa opioid receptor 
mediating locomotor activity are exclusively located in 
the central nervous system.
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CHAPTER FIVE
GENERAL METHODS
Subj ects
Subjects were 40 rat pups of Sprague-Dawley descent, 
born and raised at California State University, San 
Bernardino. Litters were culled to 10 rat pups at 
postnatal day 4 (day 0 = parturition). Only half (5) of 
the pups from each litter were utilized as subjects. One 
rat pup from each litter was randomly assigned to each 
treatment group. There were an equal number of male and 
female rats per group. The colony room was maintained at 
22-24°C and kept under a 12:12 light/dark cycle. Testing 
was done in a separate experimental room and was conducted 
during the light phase of the cycle. Subjects were treated 
according to the National Institute of Health's 
guidelines, "Guide for the Care and Use of Laboratory 
Animals" (National Research Council, 1996), under a 
research protocol that was approved by the Institutional 
Animal Care and Use Committee of California State 
University, San Bernardino.
Apparatus
Ultrasonic vocalizations were assessed in a clear
Plexiglas chamber (19 x 16 x 20 cm) housed inside a heated 
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incubator maintained at 34°C (±1°C). A Mini-3 ultrasonic 
detector (Ultrasound Advice, London, UK) was suspended 8 
cm above the floor of the behavioral testing apparatus. 
Lines divided the floor of the testing apparatus into four 
equal quadrants. The ultrasonic detector was tuned to 40 
kHz (±1 kHz), because a setting of 40-45 kHz provides the 
highest rate of ultrasonic vocalization detection .(Hofer & 
Shair, .1978). Line-crosses were visually recorded by 
observer's blind to drug treatment conditions. Rectal 
temperatures were assessed using a BAT-12 microprobe 
thermometer (Physitemp Instruments, Piscataway, NJ, USA). 
The ultrasonic vocalization and rectal temperature data 
were than entered and assessed.
Drugs
ICI 204,448 and U50,488 were purchased from Sigma
(St. Louis, MO, USA). All drugs were dissolved in sterile 
saline and injected intraperitoneally (i.p.) at a volume 
of 5 ml/kg.
Procedure
The purpose of this experiment was to determine 
whether ICI 204,448 would increase the ultrasonic 
vocalizations of preweanling rats. Eight litters of 
11-day-old rats were used, with five rats from each litter
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(N = 40) being tested. Specifically, one rat from each 
litter was injected with saline; one rat from each litter 
was administered U50,488 (2.5 mg/kg); the three remaining
rats from each litter were given one of three doses of ICI
204,448 (1.25, 2.5, or 5 mg/kg). Only one dose of U50,488 
was used, because it has been established that 2.5 mg/kg 
U50,488 produces substantial numbers of ultrasonic 
vocalizations in preweanling rats (Nazarian et al., 1999, 
2001). A broader range of ICI 204,448 (1.25-5 mg/kg) was 
used, because this compound has been used infrequently in 
behavioral studies (Shaw et al., 1989). After being 
injected, rats were returned to their home cage for 15 
minutes. After 15 minutes, each rat was individually taken 
to the experimental room and placed in the testing 
chamber. During each 20-minute session ultrasonic 
vocalizations and line-crosses (a measure of forward 
locomotion) were measured with rectal temperatures being 
recorded immediately after behavioral testing.
After testing, each rat was anesthetized using sodium 
pentobarbital and returned to the home cage. This 
procedure maintained litter size while eliminating the 
ultrasonic vocalizations of the returning rat, so neither 
declining litter size nor ultrasonic vocalizations would 
affect the remaining .pups. Specifically, it has been shown 
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that decreasing litter size and increased ultrasonic 
vocalizations can cause distress in the remaining test 
subjects in that litter (see Carden et al., 1993; Krall et 
al., 2005; Nazarian et al., 2001).
In summary, this experiment utilized one 
between-subject independent variable with five levels 
(saline, 2.5 mg/kg U50488, 1.25 mg/kg ICI 204,488, 2.5 
mg/kg ICI 204,488, 5 mg/kg ICI 204,488). Ultrasonic 
vocalization and line-cross data from each 20-minute 
session was divided into four 5-minute time blocks, so 
time served as a within-subj'ect independent variable with 
four levels. The dependent variables were ultrasonic 
vocalizations, line-crosses, and rectal temperatures.
Statistical Analysis
Analyses of variance (ANOVAs) were used for 
statistical analysis of ultrasonic vocalization, 
line-cross, and rectal temperature data. In this 
experiment, ultrasonic vocalizations and line-crosses were 
analyzed for 20 minutes, with each 20-minute session being 
divided into 4 separate 5-minute time blocks. Therefore, a 
two-way ANOVA (drug x 5 minute time block) was used to 
analyze both ultrasonic vocalizations and line-cross, 
data. Rectal temperature data were analyzed using a 
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one-way (drug) ANOVA. For these analyses, litter effects 
were controlled by using within-litter statistical 
procedures (i.e., a within analysis using one 
value/condition/litter), which considers litter, rather 
than each subject, as a degree of freedom (Zorrilla, 
1997). Tukey tests were used for making post hoc 
comparisons.
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CHAPTER SIX
RESULTS
Although it was hypothesized that ICI 204,448 would 
increase ultrasonic vocalizations and decrease rectal 
temperatures, this was only partially the case. Ultrasonic 
vocalizations of rats given peripheral injections of ICI
204,448 (1.25, 2.5, or 5 mg/kg) or U50,488 (2.5 mg/kg) did 
emit more ultrasonic vocalizations than saline-treated 
rats, drug main effect, F(4,28) =15.32, p < .001 (see 
Figure 1). The effects of the drug variable did not vary 
across the testing session. Rectal temperatures of the 
rats did not vary 'according to drug treatment (see Table 
1) •
Interestingly, when compared to saline controls, all 
doses of ICI 204,488 (1.25, 2.5, or 5 mg/kg) and U50,488 
(2.5 mg/kg) increased the line-crosses of preweanling 
rats, drug main effect, F(4,28) = 7.75, p < .001 (see 
Figure 2). On time block 2, rats given 1.25 mg/kg ICI
204,448 had more line-crosses than rats given 5 mg/kg ICI 
204,448, drug x time block interaction, F(12,84) = 2.78, 
p < .01. All of the drug groups differed from saline 
controls on time blocks, 1-4.
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Table 1. Mean (± SE) Rectal Temperatures (°C) of
Preweanling Rats (n = 8 Per Group) Injected
Intraperitoneally (ip) with Saline, ICI 204,448 or U50,488
Treatment Rectal Temperatures
Saline 36.20(± 0.16)
1.25 mg/kg ICI 204,448 36.01(± 0.20)
2.5 mg/kg ICI 204,448 35.82(± 0.18)
5.0 mg/kg ICI 204,448 36.39(± 0.13)
2.5 mg/kg U50,488 36.04(+ 0.27)
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Figure 1. Mean (+ S.E.M.) Number of Ultrasonic
Vocalizations of 11-Day-Old Rats (n = 8 Per Group) 
Injected with Saline, ICI 204,488 (1.25, 2.5, or 5 mg/kg), 
or U50,488 (2.5 mg/kg) 15 Minutes Prior to Testing.
Ultrasonic Vocalizations were Assessed for 20 Minutes
(Divided into Four 5-Minute Time Blocks)
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11-Day-Old Rats (n = 8 Per Group) Injected with Saline, 
ICI 204,488 (1.25, 2.5 & 5 mg/kg), or U50,488 (2.5 mg/kg) 
15 Minutes Prior to Testing. Line-Crosses Were Assessed 
for 20 Minutes (Divided into Four 5-Minute Time Blocks)
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CHAPTER SEVEN
DISCUSSION
The purpose of this thesis was to determine whether 
stimulating kappa opioid receptors in the peripheral 
nervous system is capable of eliciting ultrasonic 
vocalization production. Specifically, it was hypothesized 
that U50,488 and ICI 204,448 would increase ultrasonic 
vocalizations and decrease rectal temperatures, thus 
indicating that peripherally-located kappa opioid 
receptors are important for ultrasonic vocalization 
production. It was also predicted that only U50,488, and 
not ICI 204,448, would increase the locomotor activity of 
preweanling rats because kappa opioid-mediated locomotor 
activity is thought to be centrally mediated (Collins et 
al., 2000; Herrera-Marschitz, Christensson-Nylander, 
Sharp, Staines, Reid, Hokfelt, Terenius, & Ungerstedt, 
1986; Matsumoto, Brinsfield, Patrick, & Walker, 1988; 
Thompson & Walker, 1990). Results showed that rats given 
peripheral injections of ICI 204,448 (1.25, 2.5, or 5 
mg/kg) or U50,488 (2.5 mg/kg) did emit more ultrasonic 
vocalizations than saline-treated rats; however, rectal 
temperatures of rats did not decrease as a result of drug 
treatment (see Table 1). Interestingly, when compared to 
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saline controls, all doses of ICI 204,488 (1.25, 2.5, or 5 
mg/kg) and U50,488 (2.5 mg/kg) increased the line-crosses 
of preweanling rats. These U50,488-induced effects were 
expected because this drug readily crosses the blood-brain 
barrier. However, ICI 204,488 does not cross the 
blood-brain barrier of adult rats (Barber et al., 1994; 
Shaw et al., 1989), so the increased locomotor activity 
after ICI 204,488 administration was unanticipated.
As hypothesized, the results suggest that kappa 
opioid receptors in the peripheral nervous system mediate 
ultrasonic vocalization production in 11-day-old rats. 
Specifically, systemic administration of ICI 204,448, a 
kappa opioid agonist purported to be unable to cross the 
blood-brain barrier, elicited substantial ultrasonic 
vocalization production- in preweanling rats. This result 
was expected because systemic administration of U50,488, a 
kappa opioid agonist that stimulates both peripherally- 
and centrally-located kappa opioid receptors, also induces 
ultrasonic vocalizations (Barr et al., 1994; Nazarian et 
al., 2001). Interestingly, Goodwin and Barr (2005) report 
that direct infusion of U50,488 into the periaqueductal 
gray elicits ultrasonic vocalizations in young rats, thus 
indicating that centrally located kappa opioid receptors 
also mediate ultrasonic vocalization production.
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Therefore, the most parsimonious conclusion is that 
ultrasonic vocalizations of young rats are mediated 
through both central and peripheral mechanisms.
The latter conclusion needs to be tempered, however, 
because of the locomotor activity data. Specifically, ICI 
204,448's ability to increase the locomotor activity of 
preweanling rats indicates that either (a) ICI 204,448 
crossed the blood-brain barrier of preweanling rats or 
(b) peripherally-located kappa opioid receptors are 
capable of mediating locomotor activity. Although ICI 
204,488 is unable to cross the blood-brain barrier of 
adult rats (Barber et al., 1994; Shaw et al., 1989), no 
studies have assessed ICI 204,448's ability to penetrate 
the blood-brain barrier of preweanling rats. In general, 
the blood-brain barrier matures rapidly during 
embryogenesis (Risau & Wolburg, 1999), but it has been 
reported that ontogenetic changes in blood-brain barrier 
permeability can occur across the preweanling period 
(Johanson, 1980; Stewart & Hayakawa, 1987). An alternative 
possibility is that stimulating kappa opioid receptors in 
the periphery is capable of inducing locomotion. In this 
regard, it is important to note that stimulation of 
peripherally-located kappa opioid receptors induces an 
aversive state (Bechara & van der Kooy, 1987). Although 
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speculative, it is possible that this aversive state 
indirectly results in locomotion. When combined with data 
showing that U50,488-i'nduced locomotor activity was only 
partially attenuated by lesions of the ventromedial 
thalamus or superior colliculus (Zavala et al., 2002), it 
remains plausible that different populations of 
peripherally-located kappa opioid receptors separately 
mediate locomotion and ultrasonic vocalization production.
When the various results are considered together, it 
appears that kappa opioid receptors in the peripheral 
nervous system are capable of mediating ultrasonic 
vocalization production. The question remains as to 
whether this ultrasonic vocalization production is due to 
the activation of stress/emotion circuitry or the onset of 
abdominal compression reactions. As mentioned in the 
Introduction, Blumberg and colleagues (1999, 2000a, 2000b) 
have proposed that ultrasonic vocalizations are an 
"acoustic by-product" of a cardiovascular process called 
the abdominal compression reaction. Abdominal compression 
reactions are caused by any factor (i.e., cold stress, 
drug action, etc.) that reduces heart rate and venous 
blood flow. These abdominal compression reactions, in 
turn, increase blood pressure and cause a concomitant 
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increase in ultrasonic vocalizations (Blumberg et al., 
1999, 2000b).
In terms of the present thesis, Blumberg's abdominal 
compression reaction hypothesis was tenable because kappa 
opioid receptors are located on heart tissue and post 
ganglionic fibers in the peripheral nervous system and 
stimulating these receptors induces both bradycardia and 
hypotension (Pugsley et al., 1992). In the central nervous 
system, stimulation of kappa opioid receptors in the 
hippocampus, hypothalamus, medulla and, to a lesser 
extent, the periaqueductal gray decreases heart rate and 
blood pressure of adult rats (Feuerstein & Faden, 1982; 
Wang & Ingenito, 1994). Therefore, there are neural 
mechanisms in place that allow Blumberg's abdominal 
compression reaction hypothesis to remain tenable (i.e., 
kappa opioid receptors are located on neuroanatomical 
structures that could induce abdominal compression 
reactions and ultrasonic vocalizations). That being said, 
it is important to realize that neither U50,488 nor ICI 
204,488 decreased the rectal temperatures of rats (see 
Table 1). This finding is not consistent with the 
abdominal compression reaction hypothesis, because neither 
kappa opioid agonist appeared to decrease cardiovascular 
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functioning (i.e., induced abdominal compression 
reactions).
An alternative explanation is that ultrasonic 
vocalizations are an emotionally-based distress response 
(Allin & Banks, 1971, 1972; Hofer & Shair, 1978; 
Lorberbaum et al., 2002; Newman, 2007; Noirot, 1972; 
Noriuchi et al., 2008). In terms of peripherally-located 
kappa opioid receptors, it is possible that stimulating 
these receptors induces an aversive state (Bechara & van 
der Kooy, 1987) leading to an emotional response that 
initiates ultrasonic vocalization production. As reported 
by Goodwin and Barr (2005), kappa opioid receptors in the 
periaqueductal gray are also involved in mediating 
ultrasonic vocalization production. This brain region is 
important for defense responses, so it is possible that 
peripheral and central kappa opioid receptors interact to 
influence ultrasonic vocalization production by modulating 
neural mechanisms underlying emotion.
Although the kappa opioid receptor system-is clearly 
involved in modulating ultrasonic vocalization production, 
other neurotransmitter systems play important roles. For 
example, there is substantial evidence that stimulation of 
c^-adrenoceptors increases ultrasonic vocalization 
production in preweanling rat pups, although it is still 
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uncertain whether these vocalizations are due to 
modulating distress and anxiety (e.g., Kehoe & Harris, 
1989) or by altering cardiovascular functioning (e.g., 
Blumberg & Sokoloff, 2001; Blumberg et al., 2000b). 
Evidence for both positions exist, because 
a2-adrenoceptors are located in brain regions responsible 
for mediating distress and anxiety (Kehoe & Harris, 1989), 
while a2-adrenoceptor agonists (e.g., clonidine) are 
capable of decreasing heart rate .and blood pressure 
(McAuley et al., 1989; Wang et al., 1996). Regardless of 
explanation, the a2-adrenoceptors mediating ultrasonic 
vocalization production appear to be exclusively located 
in the central nervous system. Specifically, peripheral 
administration of the lipophilic a2-adrenoceptor agonist 
clonidine, which easily crosses the blood-brain barrier, 
increases ultrasonic vocalizations; whereas, peripheral 
administration of the hydrophilic a2-adrenoceptor agonist 
ST-91, which does not readily cross the blood-brain 
barrier, does not affect ultrasonic vocalization 
production (Krall et al., 2005).
Interestingly, there is evidence that the kappa 
opioid and noradrenergic systems interact to mediate 
ultrasonic vocalization production. Specifically, Nazarian 
et al. (2001) reports that an a2_adrenoceptor antagonist 
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attenuated U50,488-induced ultrasonic vocalizations; 
whereas, a kappa opioid antagonist did not block 
clonidine-induced ultrasonic vocalizations. These results 
suggest that the a2-adrenoceptor system must be functional 
for the kappa opioid system to modulate ultrasonic 
vocalizations (Nazarian et al., 2001). In terms of the 
present study, these results imply that peripherally- and 
centrally-located kappa opioid receptors interact 
complexly with other neurotransmitter systems to mediate 
ultrasonic vocalization production.
As mentioned in the Introduction, ultrasonic 
vocalizations are an important signal that elicits 
maternal behavior in adult rats (Lorberbaum et al., 2002; 
Newman, 2007; Noriuchi et al., 2008). For instance, 
maternal responses (searching) have been elicited by 
playing back recordings of ultrasonic vocalizations (Allin 
& Banks, 1972; Noriuchi et al., 2008; Wohr et al., 2005). 
Interestingly, maternal responses are based on the 
individual acoustic parameters of the calls rather than 
the number of calls (Keller et al., 2004). The ability to 
differentiate acoustic parameters probably explains why 
some calls of young rodents elicit maternal retrieval and 
others act as a main elicitor of anogenital licking, which 
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is vital to the survival of the young pups 
(Bruuette-Lahlou et al., 1992).
Analogous processes appear to occur in humans, 
because the cries of infants can induce profound emotional 
responses in human mothers (Lorberbaum et al., 2002; 
Seifritz et al., 2003). In these studies such cries lead 
to protective responses, whereas the same mothers showed 
irritable reactions to control noises. Although it is true 
that crying is often due to distress or the need for 
socialization (Bowlby, 1973, 1988), cries are also 
considered a survival mechanism that initiate bonding and 
survival of the young human (Bowlby, 1973, 1988;' Lummaa & 
Vuorialo, 1998; Seifritz et al., 2003). For instance, 
Bowlby (1973, 1988) conceived attachment as a process of 
proximity-seeking, which causes a known caregiver to 
respond and maintain closeness. In both humans and 
animals, therefore, vocalizations initiate a complex 
social interactive process that satisfies the biological 
needs of the infant (Lummaa & Vuorialo, 1998; Seifritz et 
al., 2003) by eliciting a maternal response.
In conclusion, there is little doubt that 
vocalizations (e.g., crying) elicit maternal care in both 
humans and animals, so it would not be surprising if the 
mechanisms responsible for vocalization production share a 
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common neural substrate. In this regards, it is important 
to remember that the same neural network (including the 
kappa opioid, a2-adrenoceptor and GABA systems) are 
preserved throughout invertebrate and vertebrate species 
(Ruuskanen, Laurila, Xhaard, Rantanen, Vuoriluoto, 
Wurster, Marjamaki, Vainio, Johnson, & Scheinin, 2005; 
Stevens, Brasel, & Mohan, 2007; Tsang, Ng, Xu, & Xue, 
2007), and that these neural mechanisms are activated 
during crying in rodents, nonhuman primates, and humans 
(Lorberbaum et al., 2002; Newman, 2007; Noriuchi et al., 
2008; Seifritz et al., 2003).
In the case of humans, crying has been studied using 
magnetic resonance imaging, but this technology is not 
capable of measuring the functioning of individual 
neurotransmitter systems. For this reason the neural 
mechanisms underlying human crying are poorly understood; 
however, because of the preservation of neural networks 
across species, the present thesis suggests that the kappa 
opioid neurotransmitter system may be an important neural 
mechanism mediating crying in humans. Additionally, my 
results are consistent with the traditional view that the 
ultrasonic vocalization production of young rats is caused 
by an emotional response (rather than abdominal 
compression reactions). Obviously, this conclusion is also 
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consistent with the human literature, because human crying 
is believed to be an emotional form of communication 
(Newman, 2007) signaling distress or alarm (Bowlby, 1973; 
Lummaa & Vuorialo, 1998; Seifritz et al., 2003; Stormark, 
2007).
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